BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 2551653)

  • 1. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats.
    Hurrell DG; Pedersen O; Kahn CR
    Endocrinology; 1989 Nov; 125(5):2454-62. PubMed ID: 2551653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats.
    Slieker LJ; Roberts EF; Shaw WN; Johnson WT
    Diabetes; 1990 May; 39(5):619-25. PubMed ID: 2332119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms.
    Block NE; Komori K; Robinson KA; Dutton SL; Lam CF; Buse MG
    Endocrinology; 1991 Jan; 128(1):312-22. PubMed ID: 1846101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylation of the insulin receptor partially restores the decreased autophosphorylation in streptozotocin induced diabetic rats.
    Iwama N; Watarai T; Kajimoto Y; Yamasaki Y; Yokoyama T; Kawamori R; Kamada T
    Diabetes Res; 1991 May; 17(1):25-32. PubMed ID: 1816977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased autophosphorylation of EGF receptor in insulin-deficient diabetic rats.
    Okamoto M; Kahn CR; Maron R; White MF
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E429-34. PubMed ID: 2833110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.
    Giorgino F; Almahfouz A; Goodyear LJ; Smith RJ
    J Clin Invest; 1993 May; 91(5):2020-30. PubMed ID: 7683695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of beta-naphthoflavone on insulin receptor binding and protein kinase activity in rat liver and placenta.
    Wang SL; Raizada MK; Shiverick KT
    Mol Pharmacol; 1988 Mar; 33(3):250-6. PubMed ID: 2832720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver insulin receptor tyrosine kinase activity in a rat model of type II diabetes mellitus and obesity.
    Adamo M; Shemer J; Aridor M; Dixon J; Carswell N; Bhathena SJ; Michaelis OE; LeRoith D
    J Nutr; 1989 Mar; 119(3):484-9. PubMed ID: 2537893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophosphorylation and kinase activity of insulin receptor in diabetic rats.
    Okamoto M; White MF; Maron R; Kahn CR
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E542-50. PubMed ID: 2430467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wheat germ agglutinin stimulation of alpha beta heterodimeric insulin receptor beta-subunit autophosphorylation by noncovalent association into an alpha 2 beta 2 heterotetrameric state.
    Wilden PA; Morrison BD; Pessin JE
    Endocrinology; 1989 Feb; 124(2):971-9. PubMed ID: 2536324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
    Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
    J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats.
    Bader S; Scholz R; Kellerer M; Tippmer S; Rett K; Mathaei S; Freund P; Häring HU
    Diabetologia; 1992 Aug; 35(8):712-8. PubMed ID: 1324860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal insulin receptor tyrosine kinase activity in kidney basolateral membranes from non-insulin-dependent diabetic rats.
    Grunberger G; Nagy K; Rempinski D; Levy J
    J Lab Clin Med; 1990 Jun; 115(6):704-11. PubMed ID: 2164078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor kinase is hyperresponsive in adipocytes of young obese Zucker rats.
    Debant A; Guerre-Millo M; Le Marchand-Brustel Y; Freychet P; Lavau M; Van Obberghen E
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E273-8. PubMed ID: 3548422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle insulin-receptor kinase. Effects of substrate inhibition and diabetes.
    Block NE; Komori K; Dutton SL; Robinson KA; Buse MG
    Diabetes; 1991 Dec; 40(12):1691-700. PubMed ID: 1661694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The male obese Wistar diabetic fatty rat is a new model of extreme insulin resistance.
    Greene SF; Johnson PR; Eiffert KC; Greenwoodt MR; Stern JS
    Obes Res; 1994 Sep; 2(5):432-43. PubMed ID: 16358398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural differences in human and rat-derived insulin receptors: characterization of the beta-subunit kinase activity.
    Brillon DJ; Henry RR; Klein HH; Olefsky JM; Freidenberg GR
    Endocrinology; 1988 Oct; 123(4):1837-47. PubMed ID: 2843349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene.
    Dominici FP; Balbis A; Bartke A; Turyn D
    J Endocrinol; 1998 Oct; 159(1):15-25. PubMed ID: 9795337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization and activation of the rat liver insulin receptor kinase in vivo.
    Khan MN; Baquiran G; Brule C; Burgess J; Foster B; Bergeron JJ; Posner BI
    J Biol Chem; 1989 Aug; 264(22):12931-40. PubMed ID: 2546941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.